Background illustration for clinical trials search

Paid Clinical Trials Alabama

Discover 1,123 paid clinical trials in Alabama. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or Obesity

for
Obesity, Overweight and/or Obesity, Overweight,
Location: Wilmington NC, Greensboro NC, Louisville KY, Oviedo FL,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07845500

Phase 3, Recruiting

A Study to Evaluate the Safety and Efficacy of MK-1406/CD388 for Prevention of Influenza (MK-1406-005/CD388.SQ.3.06)

for
Influenza
Location: Burlington MA, Bridgeport CT, Brooklyn NY, Annapolis MD,
Sponsor: Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Sex: All

Age: 12+

Code: NCT07159763

Phase 3, Recruiting

Post-market Evaluation of LumiSystem: Intraoperative Margin Performance and Clinical Utility (IMPACT) Registry

for
Breast Cancer
Location: Mobile AL, Palo Alto CA
Sponsor: Lumicell, Inc.

Sex: All

Age: 18+

Code: NCT07616856

Recruiting

Post-market Safety Study of LUMISIGHT

for
Hypersensitivity Reactions
Location: Mobile AL, Palo Alto CA
Sponsor: Lumicell, Inc.

Sex: All

Age: 18+

Code: NCT07572162

Recruiting

A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma

for
Squamous Cell Carcinoma of Head and Neck
Location: Boston MA, The Bronx NY, Philadelphia PA,
Sponsor: Johnson & Johnson Enterprise Innovation Inc.

Sex: All

Age: 18 - 70+

Code: NCT07219212

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

for
Endometrial Cancer, Recurrent or Progressive Endometrial Cancer
Location: Worcester MA, Hartford CT, Norwalk CT, Danbury CT,
Sponsor: Genmab

Sex: Female

Age: 18+

Code: NCT07166094

Phase 3, Recruiting

Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas

for
BRAF V600 Mutation, Low-grade Glioma, Low Grade Glioma of Brain,
Location: Hackensack NJ, Baltimore MD, Washington D.C. DC,
Sponsor: University of California, San Francisco

Sex: All

Age: 1 - 25

Code: NCT07110246

Phase 2, Recruiting

Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2

for
Intracerebral Hemorrhage
Location: Boston MA, Worcester MA, Stony Brook NY, New York NY,
Sponsor: Joseph Broderick, MD

Sex: All

Age: 18 - 70+

Code: NCT07227246

Phase 3, Recruiting

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

for
Parkinson's Disease
Location: Boston MA, New Haven CT, New York NY, Commack NY,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 50 - 70+

Code: NCT07174310

Phase 3, Recruiting

Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA

for
Aortic Arch Aneurysm, Aortic Arch Dissection,
Location: The Bronx NY, New York NY, Philadelphia PA,
Sponsor: Artivion Inc.

Sex: All

Age: 18 - 70+

Code: NCT07089576

Recruiting

Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency

for
Alpha 1-Antitrypsin, COPD, Antibody Deficiency
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham

Sex: All

Age: 19+

Code: NCT07135427

Phase 4, Recruiting

A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)

for
Apnea, Sleep Disorders, Overweight and/or Obesity
Location: Bradenton FL, Cullman AL, Little Rock AR, Maplewood MN,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07823608

Phase 3, Recruiting

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)

for
Cervical Cancer
Location: Halifax, Providence RI, Quebec, Sherbrooke, Mineola NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT07216703

Phase 3, Recruiting

High-energy Human Milk Diets in the First Two Weeks After Birth to Reduce BPD in Extremely Preterm Infants

for
Extreme Prematurity, Enteral Nutrition,
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham

Sex: All

Age: 0

Code: NCT07307612

Phase 1, Phase 2, Recruiting

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)

for
Chronic Kidney Disease(CKD), Type 2 DM,
Location: Durham NC, Houston NC, St. Petersburg FL, Ann Arbor MI,
Sponsor: Duke University

Sex: All

Age: 18+

Code: NCT06906627

Recruiting

Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure

for
Heart Failure - NYHA II - IV
Location: Fall River MA, Flushing NY, New York NY, Albany NY,
Sponsor: Boston Scientific Corporation

Sex: All

Age: 18+

Code: NCT07069738

Recruiting

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)

for
Chronic Kidney Disease(CKD), Type 2 DM,
Location: Durham NC, St. Petersburg FL, Ann Arbor MI,
Sponsor: Duke University

Sex: All

Age: 18+

Code: NCT06906640

Recruiting

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

for
Atherosclerosis, Cardiovascular Disease, Obesity, Hypertension,
Location: Foxborough MA, The Bronx NY, Yardley PA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07783802

Phase 2, Recruiting

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

for
Diffuse Midline Glioma, H3 K27-Altered,
Location: Boston MA, Valhalla NY, New York NY, Philadelphia PA,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 21

Code: NCT04870944

Phase 1, Phase 2, Recruiting

Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

for
Pancreatic Cancer, PDAC,
Location: Boston MA, Hartford CT, New York NY, New Brunswick NJ,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT07252232

Phase 3, Recruiting

Popular cities in Alabama